Grant Warren Hladun Insider Profile
4 Followers
Grant Warren Hladun, Director at Pharmacorp Rx Inc., holds 1.05M shares in Pharmacorp Rx Inc. (Ticker: TSE:PCRX). Most recently, Grant Warren Hladun Bought 173,333 shares of Pharmacorp Rx Inc. on Jul 16, 2026 for an estimated value of C$88.40K.
Grant Warren Hladun's Trading History
| PCRXPharmacorp Rx Inc. | Jul 16, 2026 | Director | Informative Buy | 88.40K | C$432.28K | ||||||||||||||||||||||
TSE:PCRX Insider Shares: 1.05M (60.57%)
| |||||||||||||||||||||||||||
You May Also Like
Grant Warren Hladun insider profile FAQ
What is the percentage of profitable transactions made by Grant Warren Hladun?
The percentage of profitable transactions made by Grant Warren Hladun is 0%.
What is the average return per transaction made by Grant Warren Hladun?
The average return per transaction made by Grant Warren Hladun is -11.50%.
What stocks does Grant Warren Hladun hold?
Grant Warren Hladun holds: TSE:PCRX stocks.
What was Grant Warren Hladun’s latest transaction?
Grant Warren Hladun’s latest transaction was an Informative Buy of C$88.40K.
What was Grant Warren Hladun's most profitable transaction?
Grant Warren Hladun’s most profitable transaction was an Informative Buy of TSE:PCRX stock on November 14, 2025. The return on the trade was -3.50%.
What is Grant Warren Hladun's role in Pharmacorp Rx Inc.?
Grant Warren Hladun's role in Pharmacorp Rx Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
